Our main aim was to describe the effect on the severity of ACEI (angiotensin-converting
enzyme inhibitor) and ARB (angiotensin II receptor blocker) during COVID-19 hospitalization. A …

Uncontrolled inflammation following COVID-19 infection is an important characteristic of the
most seriously ill patients. The present study aims to describe the clusters of inflammation in …

We aimed to determine the impact of steroid use in COVID-19 in-hospital mortality, in a
retrospective cohort study of the SEMICOVID19 database of admitted patients with SARS-CoV-2 …

Some patients with a recent ischemic stroke who are being treated with aspirin as an
antiaggregant suffer a new ischemic stroke. These patients (15–25%) have been called …

Aspirin (ASA), the most commonly used antiplatelet agent, prevents stroke recurrence
among patients with a recent stroke or transient ischemic attack (TIA). In a meta-regression …

Algunos enfermos con ictus isquémico que siguen tratamiento con aspirina como
antiagregante presentan un nuevo ictus isquémico. Estos pacientes han sido llamados «resistentes» …

Mujer de 65 años derivada a consultas externas de Medicina Interna desde su centro de
salud para control de glucemias, con HbA1c 9.4%, a pesar de tratamiento con insulina pauta …

Background The use of ACEI (Angiotensin-Converting Enzyme Inhibitor) and ARB (Angiotensin
II Receptor Blocker) in COVID-19 remains controversial. Our main aim was to describe …

… María Sierra Navas-Alcantara …

… Castilla Guerra, Luis; Fernández Moreno, M Carmen; Navas Alcántara, M Sierra; Jiménez
Hernández, M Dolores. … Navas Alcántara, M Sierra; Hospital de la Merced. Sevilla. España …